average monthly weight loss tirzepatide Per Week average weight loss on tirzepatide

These therapies are often considered when insulin resistance, persistent fat storage, or plateaus limit progress

This pharmacological profile contributes to its off-label use in managing conditions like anxiety, depression augmentation, and binge eating disorder FDA-Approved and Off-Label Uses FDA-Approved Use: Attention-Deficit/Hyperactivity Disorder (ADHD) in children (age 6+), adolescents, and adults Off-Label Uses: Generalized Anxiety Disorder (GAD) Treatment-resistant depression (as augmentation) Binge Eating Disorder (BED) Obsessive-Compulsive Disorder (OCD) Executive dysfunction in autism spectrum disorders Always consult a licensed medical provider for off-label usage

1 Anxiety affects around 8 million people in the UK at any given time and is strongly associated with obesity

Results may vary based on metabolism, starting weight, and overall health

Its level begins to decline rapidly when we are under chronic stress, eat unhealthily, take medication regularly, and after the age of 40